These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17333591)

  • 21. Ethical and legal implications of pharmacogenomics.
    Rothstein MA; Epps PG
    Nat Rev Genet; 2001 Mar; 2(3):228-31. PubMed ID: 11256075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution of pharmacogenomics.
    Somogy A
    Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implications of pharmacogenomics for drug development and clinical practice.
    Ginsburg GS; Konstance RP; Allsbrook JS; Schulman KA
    Arch Intern Med; 2005 Nov; 165(20):2331-6. PubMed ID: 16287761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A lay prescription for tailor-made drugs--focus group reflections on pharmacogenomics.
    Almarsdóttir AB; Björnsdóttir I; Traulsen JM
    Health Policy; 2005 Feb; 71(2):233-41. PubMed ID: 15607385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of FDA guidance on pharmacogenomic data submissions on drug development.
    Little S
    IDrugs; 2005 Aug; 8(8):648-50. PubMed ID: 16044373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenomics: a new clinical or regulatory paradigm? European experiences of pharmacogenomics in drug regulation and regulatory initiatives.
    Prasad K; Breckenridge A
    Drug Discov Today; 2011 Oct; 16(19-20):867-72. PubMed ID: 21920454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allied against reform: pharmaceutical industry-academic physician relations in the United States, 1945-1970.
    Tobbell DA
    Bull Hist Med; 2008; 82(4):878-912. PubMed ID: 19075387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. With your genes? Take one of these, three times a day.
    Abbott A
    Nature; 2003 Oct; 425(6960):760-2. PubMed ID: 14574377
    [No Abstract]   [Full Text] [Related]  

  • 29. Separating predictive genetic testing from snake oil: regulation, liabilities, and lost opportunities.
    Malinowski MJ
    Jurimetrics; 2000; 41(1):23-52. PubMed ID: 15744897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenetics goes genomic.
    Goldstein DB; Tate SK; Sisodiya SM
    Nat Rev Genet; 2003 Dec; 4(12):937-47. PubMed ID: 14631354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medicine, government, and the human genome.
    Larson JS
    J Health Hum Serv Adm; 2001; 24(3):321-30. PubMed ID: 14998287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotypic approaches to therapy in children: a national active surveillance network (GATC) to study the pharmacogenomics of severe adverse drug reactions in children.
    Ross CJ; Carleton B; Warn DG; Stenton SB; Rassekh SR; Hayden MR
    Ann N Y Acad Sci; 2007 Sep; 1110():177-92. PubMed ID: 17911433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Policy implications of drug importation.
    Palumbo FB; Mullins CD; Slagle AF; Rizer J
    Clin Ther; 2007 Dec; 29(12):2758-67. PubMed ID: 18201594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic advantage of pharmacogenomics - clinical trials with genetic information.
    Ohashi W; Mizushima H; Tanaka H
    Stud Health Technol Inform; 2008; 136():585-90. PubMed ID: 18487794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Should pharmacogenomic studies be required for new drug approval?
    Relling MV; Hoffman JM
    Clin Pharmacol Ther; 2007 Mar; 81(3):425-8. PubMed ID: 17339872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pushing drugs: genomics and genetics, the pharmaceutical industry, and the law of negligence.
    Feldman HL
    Washburn Law J; 2003; 42(3):575-99. PubMed ID: 15115000
    [No Abstract]   [Full Text] [Related]  

  • 37. The human genome project: opportunities, challenges and consequences for population screening.
    Christodoulou J
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():234-8. PubMed ID: 15906744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. After the breakthrough. It will take years to turn genetic data into drugs.
    Sherrid P
    US News World Rep; 2001 Feb; 130(8):48. PubMed ID: 11234123
    [No Abstract]   [Full Text] [Related]  

  • 40. [Contributions of pharmacogenomics to enhance the efficiency of randomized clinical trials].
    de Jesús Castillejos-López M; García-Sancho MC; Torres-Espíndola LM; Pérez-Padilla JR
    Rev Invest Clin; 2006; 58(5):512-24. PubMed ID: 17408112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.